Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2017

Open Access 01-12-2017 | Research

The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation

Authors: P. Kamudoni, B. Mueller, J. Halford, A. Schouveller, B. Stacey, M.S. Salek

Published in: Health and Quality of Life Outcomes | Issue 1/2017

Login to get access

Abstract

Background

An understanding of the daily life impacts of hyperhidrosis and how patients deal with them, based on qualitative research, is lacking. This study investigated the impact of hyperhidrosis on the daily life of patients using a mix of qualitative research methods.

Methods

Participants were recruited through hyperhidrosis patient support groups such as the Hyperhidrosis Support Group UK. Data were collected using focus groups, interviews and online surveys. A grounded theory approach was used in the analysis of data transcripts. Data were collected from 71 participants, out of an initial 100 individuals recruited.

Results

Seventeen major themes capturing the impacts of hyperhidrosis were identified; these covered all areas of life including daily life, psychological well-being, social life, professional /school life, dealing with hyperhidrosis, unmet health care needs and physical impact.

Conclusions

Psychosocial impacts are central to the overall impacts of hyperhidrosis, cutting across and underlying the limitations experienced in other areas of life.
Appendix
Available only for authorised users
Literature
1.
go back to reference Solish N, Benohanian A, Kowalski JW. Prospective open-label study of botulinum toxin type a in patients with axillary hyperhidrosis: effects on functional impairment and quality of life. Dermatol surg. 2005;31:405–13.CrossRefPubMed Solish N, Benohanian A, Kowalski JW. Prospective open-label study of botulinum toxin type a in patients with axillary hyperhidrosis: effects on functional impairment and quality of life. Dermatol surg. 2005;31:405–13.CrossRefPubMed
2.
go back to reference Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51:241–8.CrossRefPubMed Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51:241–8.CrossRefPubMed
3.
go back to reference Augustin M, Radtke MA, Herberger K, Kornek T, Heigel H, Schaefer I. Prevalence and disease burden of hyperhidrosis in the adult population. Dermatology. 2013;227:10–3.CrossRefPubMed Augustin M, Radtke MA, Herberger K, Kornek T, Heigel H, Schaefer I. Prevalence and disease burden of hyperhidrosis in the adult population. Dermatology. 2013;227:10–3.CrossRefPubMed
4.
go back to reference Fujimoto T, Kawahara K, Yokozeki H. Epidemiological study and considerations of primary focal hyperhidrosis in Japan: from questionnaire analysis. J Dermatol. 2013;40:886–90.CrossRefPubMed Fujimoto T, Kawahara K, Yokozeki H. Epidemiological study and considerations of primary focal hyperhidrosis in Japan: from questionnaire analysis. J Dermatol. 2013;40:886–90.CrossRefPubMed
5.
go back to reference Lima SO, Aragao JF, Machado Neto J, Almeida KB, Menezes LM, Santana VR. Research of primary hyperhidrosis in students of medicine of the state of Sergipe, Brazil. An Bras Dermatol. 2015;90:661–5.CrossRefPubMedPubMedCentral Lima SO, Aragao JF, Machado Neto J, Almeida KB, Menezes LM, Santana VR. Research of primary hyperhidrosis in students of medicine of the state of Sergipe, Brazil. An Bras Dermatol. 2015;90:661–5.CrossRefPubMedPubMedCentral
6.
go back to reference Sayeed RA, Nyamekye I, Ghauri AS, Poskitt KR: Quality of life after transthoracic endoscopic sympathectomy for upper limb hyperhidrosis. Eur J Surg Suppl 1998;164(S1):39–42. Sayeed RA, Nyamekye I, Ghauri AS, Poskitt KR: Quality of life after transthoracic endoscopic sympathectomy for upper limb hyperhidrosis. Eur J Surg Suppl 1998;164(S1):39–42.
7.
go back to reference Young O, Neary P, Keaveny TV, Mehigan D, Sheehan S. Evaluation of the impact of transthoracic endoscopic sympathectomy on patients with palmar hyperhydrosis. Eur J Vasc Endovasc Surg. 2003;26:673–6.CrossRefPubMed Young O, Neary P, Keaveny TV, Mehigan D, Sheehan S. Evaluation of the impact of transthoracic endoscopic sympathectomy on patients with palmar hyperhydrosis. Eur J Vasc Endovasc Surg. 2003;26:673–6.CrossRefPubMed
8.
go back to reference Schmidt J, Bechara FG, Altmeyer P, Zirngibl H. Endoscopic thoracic sympathectomy for severe hyperhidrosis: impact of restrictive denervation on compensatory sweating. Ann Thorac Surg. 2006;81:1048–55.CrossRefPubMed Schmidt J, Bechara FG, Altmeyer P, Zirngibl H. Endoscopic thoracic sympathectomy for severe hyperhidrosis: impact of restrictive denervation on compensatory sweating. Ann Thorac Surg. 2006;81:1048–55.CrossRefPubMed
9.
go back to reference Cina CS, Robertson SG, Young EJ, Cartier B, Clase CM. Effect of endoscopic sympathectomy for hyperhidrosis on quality of life using the illness intrusiveness rating scale. Minerva Chir. 2006;61:231–9.PubMed Cina CS, Robertson SG, Young EJ, Cartier B, Clase CM. Effect of endoscopic sympathectomy for hyperhidrosis on quality of life using the illness intrusiveness rating scale. Minerva Chir. 2006;61:231–9.PubMed
10.
go back to reference Naumann MK, Hamm H, Lowe NJ, On Behalf Of The Botox® Hyperhidrosis Clinical Study G. Effect of botulinum toxin type a on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br j dermatol. 2002;147:1218–26.CrossRefPubMed Naumann MK, Hamm H, Lowe NJ, On Behalf Of The Botox® Hyperhidrosis Clinical Study G. Effect of botulinum toxin type a on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br j dermatol. 2002;147:1218–26.CrossRefPubMed
11.
go back to reference Rosell K, HyMNELIUS K, Swartling C. Botulinum toxin type a and b improve quality of life in patients with axillary and palmar hyperhidrosis. Acta Derm Venereol. 2012. Rosell K, HyMNELIUS K, Swartling C. Botulinum toxin type a and b improve quality of life in patients with axillary and palmar hyperhidrosis. Acta Derm Venereol. 2012.
12.
go back to reference Amini M, Harmsze AM, Tupker RA. Patient's estimation of efficacy of various hyperhidrosis treatments in a dermatological clinic. Acta Derm Venereol. 2008;88:356–62.PubMed Amini M, Harmsze AM, Tupker RA. Patient's estimation of efficacy of various hyperhidrosis treatments in a dermatological clinic. Acta Derm Venereol. 2008;88:356–62.PubMed
13.
go back to reference Tupker RA, Harmsze AM, Deneer VH. Oxybutynin therapy for generalized hyperhidrosis. Arch Dermatol. 2006;142:1065.CrossRefPubMed Tupker RA, Harmsze AM, Deneer VH. Oxybutynin therapy for generalized hyperhidrosis. Arch Dermatol. 2006;142:1065.CrossRefPubMed
14.
go back to reference Tan SR, Solish N. Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin a. Dermatol Surg. 2002;28:495–9.PubMed Tan SR, Solish N. Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin a. Dermatol Surg. 2002;28:495–9.PubMed
15.
go back to reference Muller C, Berensmeier A, Hamm H, Dirschka T, Reich K, Fischer T, et al. Efficacy and safety of methantheline bromide (vagantin((r))) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial. J Eur Acad Dermatol Venereol. 2012;27:1278–84.PubMed Muller C, Berensmeier A, Hamm H, Dirschka T, Reich K, Fischer T, et al. Efficacy and safety of methantheline bromide (vagantin((r))) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial. J Eur Acad Dermatol Venereol. 2012;27:1278–84.PubMed
16.
go back to reference Swartling C, Naver H, Lindberg M. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. In Eur J Neurol. 2001;8:247-52. Swartling C, Naver H, Lindberg M. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. In Eur J Neurol. 2001;8:247-52.
17.
go back to reference Campanati A, Penna L, Guzzo T, Menotta L, Silvestri B, Lagalla G, Gesuita R, Offidani A. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study. In Clin Ther. 2003;25:298-308. Campanati A, Penna L, Guzzo T, Menotta L, Silvestri B, Lagalla G, Gesuita R, Offidani A. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study. In Clin Ther. 2003;25:298-308.
18.
go back to reference Campanati A, Sandroni L, Gesuita R, Giuliano A, Giuliodori K, Marconi B, et al. Treatment of focal idiopathic hyperhidrosis with botulinum toxin type a: clinical predictive factors of relapse-free survival. J Eur Acad Dermatol Venereol. 2010;25(8):917–921. Campanati A, Sandroni L, Gesuita R, Giuliano A, Giuliodori K, Marconi B, et al. Treatment of focal idiopathic hyperhidrosis with botulinum toxin type a: clinical predictive factors of relapse-free survival. J Eur Acad Dermatol Venereol. 2010;25(8):917–921.
19.
go back to reference Kim WO, Kil HK, Yoon KB, Yoo JH. Treatment of generalized hyperhidrosis with oxybutynin in post-menopausal patients. Acta Derm Venereol. 2010;90:291–3.CrossRefPubMed Kim WO, Kil HK, Yoon KB, Yoo JH. Treatment of generalized hyperhidrosis with oxybutynin in post-menopausal patients. Acta Derm Venereol. 2010;90:291–3.CrossRefPubMed
20.
go back to reference Bechara FG, Gambichler T, Bader A, Sand M, Altmeyer P, Hoffmann K. Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage. In J Am Acad Dermatol. 2007;57:207–12. Bechara FG, Gambichler T, Bader A, Sand M, Altmeyer P, Hoffmann K. Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage. In J Am Acad Dermatol. 2007;57:207–12.
21.
go back to reference Innocenzi D, Lupi F, Bruni F, Frasca M, Panetta C, Milani M. Efficacy of a new aluminium salt thermophobic foam in the treatment of axillary and palmar primary hyperhidrosis: a pilot exploratory trial. Curr Med Res Opin. 2005;21:1949–53.CrossRefPubMed Innocenzi D, Lupi F, Bruni F, Frasca M, Panetta C, Milani M. Efficacy of a new aluminium salt thermophobic foam in the treatment of axillary and palmar primary hyperhidrosis: a pilot exploratory trial. Curr Med Res Opin. 2005;21:1949–53.CrossRefPubMed
22.
go back to reference Lupin M, Hong HC, O'Shaughnessy KF. Long-term efficacy and quality of life assessment for treatment of axillary hyperhidrosis with a microwave device. Dermatol Surg. 2014;40:805–7.PubMed Lupin M, Hong HC, O'Shaughnessy KF. Long-term efficacy and quality of life assessment for treatment of axillary hyperhidrosis with a microwave device. Dermatol Surg. 2014;40:805–7.PubMed
23.
go back to reference Hamm H, Naumann MK, Kowalski JW, Kutt S, Kozma C, Teale C. Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology. 2006;212:343–53.CrossRefPubMed Hamm H, Naumann MK, Kowalski JW, Kutt S, Kozma C, Teale C. Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology. 2006;212:343–53.CrossRefPubMed
24.
go back to reference Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Investig Dermatol. 2005;125:659–64.CrossRefPubMed Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Investig Dermatol. 2005;125:659–64.CrossRefPubMed
25.
go back to reference Thomas M, Pieretti L, Swaile D, Capretta A, Hill T. Panel discussions among hyperhidrosis patients to assess lifestyle limitations, treatment regimes, and compensating behaviors. March 3-7, 64th Annual Meeting of the American Academy of Dermatology. San Fransisco; 2006. Thomas M, Pieretti L, Swaile D, Capretta A, Hill T. Panel discussions among hyperhidrosis patients to assess lifestyle limitations, treatment regimes, and compensating behaviors. March 3-7, 64th Annual Meeting of the American Academy of Dermatology. San Fransisco; 2006.
26.
go back to reference Kerr C, Nixon A, Wild D. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert Rev Pharmacoecon Outcomes Res. 2010;10:269–81.CrossRefPubMed Kerr C, Nixon A, Wild D. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert Rev Pharmacoecon Outcomes Res. 2010;10:269–81.CrossRefPubMed
27.
go back to reference Pope C, Mays N. Qualitative research in health care. 3rd ed. Oxford: Wiley-Blackwell; 2008. Pope C, Mays N. Qualitative research in health care. 3rd ed. Oxford: Wiley-Blackwell; 2008.
28.
go back to reference Creswell JW. Qualitative inquiry and research design: choosing among five approaches. London: SAGE Publications; 2012. Creswell JW. Qualitative inquiry and research design: choosing among five approaches. London: SAGE Publications; 2012.
29.
go back to reference Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument. Value Health. 2011;14:967–77.CrossRefPubMed Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument. Value Health. 2011;14:967–77.CrossRefPubMed
30.
go back to reference Bowen GA. Grounded theory and sensitizing concepts. Int J Qualitative Methods. 2006;5:12–23. Bowen GA. Grounded theory and sensitizing concepts. Int J Qualitative Methods. 2006;5:12–23.
31.
go back to reference Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.CrossRef Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.CrossRef
32.
33.
go back to reference Beltraminelli H, Itin P. Skin and psyche – from the surface to the depth of the inner world. J Der Deutschen Dermatologischen Gesellschaft. 2008;6:8–14.CrossRef Beltraminelli H, Itin P. Skin and psyche – from the surface to the depth of the inner world. J Der Deutschen Dermatologischen Gesellschaft. 2008;6:8–14.CrossRef
34.
go back to reference Park EJ, Han KR, Choi H, Kim do W, Kim C. An epidemiological study of hyperhidrosis patients visiting the Ajou University Hospital hyperhidrosis center in Korea. J Korean Med Sci. 2010;25:772–5.CrossRefPubMedPubMedCentral Park EJ, Han KR, Choi H, Kim do W, Kim C. An epidemiological study of hyperhidrosis patients visiting the Ajou University Hospital hyperhidrosis center in Korea. J Korean Med Sci. 2010;25:772–5.CrossRefPubMedPubMedCentral
35.
go back to reference Golics C, Basra M, Finlay A, Salek M. Adolescents with skin disease have specific quality of life issues. Dermatology. 2009;218:357–66.CrossRefPubMed Golics C, Basra M, Finlay A, Salek M. Adolescents with skin disease have specific quality of life issues. Dermatology. 2009;218:357–66.CrossRefPubMed
36.
go back to reference Kamudoni P, Mueller B, Salek M. The development and validation of a disease-specific quality of life measure in hyperhidrosis: the Hyperhidrosis quality of life index (HidroQOL©). Qual Life res. 2015;24:1017–27.CrossRefPubMed Kamudoni P, Mueller B, Salek M. The development and validation of a disease-specific quality of life measure in hyperhidrosis: the Hyperhidrosis quality of life index (HidroQOL©). Qual Life res. 2015;24:1017–27.CrossRefPubMed
Metadata
Title
The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation
Authors
P. Kamudoni
B. Mueller
J. Halford
A. Schouveller
B. Stacey
M.S. Salek
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2017
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-017-0693-x

Other articles of this Issue 1/2017

Health and Quality of Life Outcomes 1/2017 Go to the issue